Clinical trial
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
NCT03194815
Study timeline
Study start (actual)2017-11-01Date precision: day
Registry last updated2026-05-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Psychosisunresolved
Autoimmune Encephalitisunresolved
Interventions
Sponsors & collaborators
University of Cambridgelead sponsor
University of Oxfordcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03194815 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.